SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001654954-20-000383
Filing Date
2020-01-13
Accepted
2020-01-13 17:09:55
Documents
5

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO REGISTRATION STATEMENT azrxs1a_jan2020.htm S-1/A 806150
2 OPINION ON LEGALITY ex5-1.htm EX-5 10891
3 CONSENTS OF EXPERTS AND COUNSEL ex23-2.htm EX-23 4591
4 IMAGE azrx.jpg GRAPHIC 4554
5 IMAGE ex5-1000.jpg GRAPHIC 3851
  Complete submission text file 0001654954-20-000383.txt   834549
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-235768 | Film No.: 20524321
SIC: 2834 Pharmaceutical Preparations